ID: ALA2437311

Max Phase: Preclinical

Molecular Formula: C15H24N2O3

Molecular Weight: 280.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)C(=O)ONC(=O)CC12CC3CC(CC(C3)C1)C2

Standard InChI:  InChI=1S/C15H24N2O3/c1-17(2)14(19)20-16-13(18)9-15-6-10-3-11(7-15)5-12(4-10)8-15/h10-12H,3-9H2,1-2H3,(H,16,18)

Standard InChI Key:  JVPWFISJJGAHNL-UHFFFAOYSA-N

Associated Targets(non-human)

Botulinum neurotoxin type A 238 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 280.37Molecular Weight (Monoisotopic): 280.1787AlogP: 2.32#Rotatable Bonds: 2
Polar Surface Area: 58.64Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.91CX Basic pKa: CX LogP: 1.76CX LogD: 1.76
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.79Np Likeness Score: -0.54

References

1. Silhár P, Eubanks LM, Seki H, Pellett S, Javor S, Tepp WH, Johnson EA, Janda KD..  (2013)  Targeting botulinum A cellular toxicity: a prodrug approach.,  56  (20): [PMID:24127873] [10.1021/jm400873n]

Source